Taipei, Taiwan

Steven Sheng-Shih Wang

This inventor holds 1 USPTO granted patent. Top assignee: Academia Sinica. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Steven Sheng-Shih Wang. Retrieved from https://idiyas.com/inventor/steven-sheng-shih-wang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Steven Sheng-Shih Wang: Innovator in Alzheimer's Disease Treatment

Introduction

Steven Sheng-Shih Wang is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of Alzheimer's disease research through his innovative methods aimed at enhancing neprilysin activity.

Latest Patents

Wang holds a patent titled "Methods for enhancing neprilysin activity and degrading amyloid-beta peptides and oligomers in a subject with Alzheimer's disease." This patent discloses a method for enhancing neprilysin activity and degrading amyloid-β peptides and oligomers in individuals suffering from Alzheimer's disease. The method involves administering a compound in a therapeutically effective amount to improve symptoms and retard the progression of the disease.

Career Highlights

Wang is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work focuses on developing therapeutic strategies for Alzheimer's disease, showcasing his commitment to advancing medical science.

Collaborations

Wang has collaborated with esteemed colleagues, including Chaur-Jong Hu and Po-Ting Chen, to further his research and enhance the impact of his findings.

Conclusion

Steven Sheng-Shih Wang's innovative approach to treating Alzheimer's disease through his patented methods highlights his dedication to improving patient outcomes. His contributions to the field are invaluable and reflect the importance of ongoing research in combating neurodegenerative diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…